|
1.
|
Chaudary MA: Patterns and recurrence in
western and Japanese women with breast cancer. Breast Cancer Res
Treat. 18:S115–S118. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Early Breast Cancer Trialists’
Collaborative Group: Tamoxifen for early breast cancer: an overview
of the randomised trials. Lancet. 351:1451–1467. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Spitale A, Mazzola P, Soldini D, et al: A
breast cancer classification according to immunohistochemical
markers: clinicopathologic features and short-term survival
analysis in a population-based study from the South of Switzerland.
Ann Oncol. 20:628–635. 2009. View Article : Google Scholar
|
|
4.
|
Brandes AA, Franceschi E, Tosoni A, et al:
Trastuzumab and lapatinib beyond trastuzumab progression for
metastatic breast cancer: strategies and pitfalls. Expert Rev
Anticancer Ther. 10:179–184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Nukatsuka M, Fujioka A, Nakagawa F, et al:
Antimetastatic and anticancer activity of S-1, a new oral
dihydropyrimidinedehydrogenase-inhibiting fluoropyrimidine, alone
and in combination with paclitaxel in an orthotopically implanted
human breast cancer model. Int J Oncol. 25:1531–1536. 2004.
|
|
6.
|
Rae JM, Creighton CJ, Meck JM, et al: MD
MDA-MB-435 cells are derived from M14 melanoma cells – a loss for
breast cancer, but a boon for melanoma research. Breast Cancer Res
Treat. 104:13–19. 2007.PubMed/NCBI
|
|
7.
|
Cailleau R, Young R, Olivé M and Reeves WJ
Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer
Inst. 53:661–674. 1974.PubMed/NCBI
|
|
8.
|
Fukushima M, Satake H, Uchida J, et al:
Preclinical antitumor efficacy of S-1: a new oral formulation of
5-fluorouracil on human tumor xenografts. Int J Oncol. 13:693–698.
1998.PubMed/NCBI
|
|
9.
|
Saeki T, Takashima S, Sano M, et al: A
phase II study of S-1 in patients with metastatic breast cancer – a
Japanese trial by the S-1 Cooperative Study Group, Breast Cancer
Working Group. Breast Cancer. 11:194–202. 2002.
|
|
10.
|
Shien T, Shimizu C, Akashi-Tanaka S, et
al: Clinical efficacy of S-1 in pretreated metastatic breast cancer
patients. Jpn J Clin Oncol. 38:172–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Price JE, Polyzos A, Zhang RD, et al:
Tumorigenicity and metastasis of human breast carcinoma cell lines
in nude mice. Cancer Res. 50:717–721. 1990.PubMed/NCBI
|
|
12.
|
Kleinman HK, McGarvey ML, Liotta LA, et
al: Isolation and characterization of type IV procollagen, laminin,
and heparan sulfate proteoglycan from the EHS sarcoma. Biochem.
21:6188–6193. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Fidler IJ: Rationale and methods for the
use of nude mice to study the biology and therapy of human cancer
metastasis. Cancer Metastasis Rev. 5:29–49. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Paget S: The distribution of secondary
growths in cancer of the breast. Cancer Metastasis Rev. 8:98–101.
1989.PubMed/NCBI
|
|
15.
|
Munoz R, Man S, Shaked Y, et al: Highly
efficacious nontoxic preclinical treatment for advanced metastatic
breast cancer using combination oral UFT-cyclophosphamide
metronomic chemotherapy. Cancer Res. 66:3386–3391. 2006. View Article : Google Scholar
|
|
16.
|
Ishikawa T, Sekiguchi F, Fukase Y, et al:
Positive correlation between the efficacy of capecitabine and
doxifluridine and the ratio of thymidine phosphorylase to
dihydropyrimidine dehydrogenase activities in tumors in human
cancer xenografts. Cancer Res. 58:685–690. 1998.
|
|
17.
|
Ajani JA, Rodriguez W, Bodoky G, et al:
Multicenter phase III comparison of cisplatin/S-1 with
cisplatin/infusional fluorouracil in advanced gastric or
gastroesophageal adenocarcinoma study: the FLAGS trial. J Clin
Oncol. 28:1547–1553. 2010. View Article : Google Scholar
|
|
18.
|
Ito Y, Nakanishi H, Kodera Y, et al:
Characterization of a novel lymph node metastasis model from human
colonic cancer and its preclinical use for comparison of
anti-metastatic efficacy between oral S-1 and UFT/ LV. Cancer Sci.
101:1853–1860. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Van den Brande J, Schöffski P, Schellens
JH, et al: EORTC Early Clinical Studies Group early phase II trial
of S-1 in patients with advanced or metastatic colorectal cancer.
Br J Cancer. 88:648–653. 2003.
|
